NVAX trade ideas: every closed DuckWise idea on Novavax, Inc.

DuckWise has published 1 idea on Novavax, Inc. (NVAX, Stock) that has closed between October 2021 and November 2021. Each is listed below with the levels published before the position was taken and its result at close — 1 in profit, 0 at a loss.

1closed idea

1 / 0in profit / at a loss

+20.26%average result

23 daystypical holding period

Opened	Closed	Side	Entry	Stop	Projection	Close	Result	Days
Oct 11, 2021	Nov 3, 2021	Long	167.27	—	195	201.16	+20.26%	23

Prices in US dollars. Result is the price change from the published entry to the published close, before fees, taxes and slippage. How results are counted.

About Novavax, Inc.

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. Does not pay dividends.

These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell NVAX or any other security.